Stem Cell Therapy Market: By Treatment (Allogeneic, Autologous), By Cell Type (Adult Stem Cells, Induced Pluripotent Stem Cells, Human Embryonic Stem Cells, Others), By Technology (Cell Production, Cell Acquisition, Cryopreservation), By End-User (Hospitals, Ambulatory Surgical Centers, Research Centers) and Geography.  

Stem Cell Therapy Market size was valued at USD 16.5 billion in 2023 and is poised to reach USD 32.2 billion by 2030, at a CAGR of 10% from 2024-2030. Stem cell therapy involves use of stem cells to treat various diseases or disorders. Stem cells are fundamental for every organ and tissue in the body. Stem cells are indistinguishable biological cells that are able to differentiate into specialised cells (liver cells, cardiac cells etc.) and can renew itself (through mitosis) to produce more stem cells. Stem cells have the ability to replicate, repair, and replace other damaged tissues in the human body. In addition, stem cell based therapies are also used to treat several chronic diseases such as blood disorders, cancer and others. Stakeholders in stem cell therapy such as academic institutions and research firms are collaborating in development of stem cell therapy and industry collaborations also projecting enormous growth of stem cell therapy market. 

Stem Cell Therapy Market Key Developments:

• For instance, in November 2015, Cellular Dynamics International, Inc. (FUJIFILM) collaborated with Roche to supply iCell (CDI's induced pluripotent stem cell derived) products that enables in identification of novel drug candidates at the early stages of drug discovery. 
• Similarly, in May 2017, Magenta Therapeutics, entered into strategic partnership with Be The Match BioTherapies, to improve and expand the use of curative stem cell transplantation.